Arcellx(us:ACLX)

    75.51

    -0.04%

    Updated on 2024-12-23

    Open:75.13
    Close:75.51
    High:76.28
    Low:74.11
    Pre Close:75.54
    Volume:147243.00
    Amount:11.10M
    Turnover:0.27%
    Shares:54.07M
    MarketCap:4.08B

    About Arcellx Company

    Arcellx, Inc is a clinical-stage biotechnology company, which provides cell therapy through the development of innovative immunotherapies for patients with cancer and other incurable diseases. The company was founded by David M. Hilbert and Luba Zaritskaya in December 2014 and is headquartered in Gaithersburg, MD.

    Company Name: Arcellx
    Company Address: 25 West Watkins Mill Road,Suite A
    Employees: 130
    Fiscar Year: 12-31
    IPO Date: 2022-02-04
    CIK: 1786205

    View all SEC Filings

    About

    Arcellx, Inc is a clinical-stage biotechnology company, which provides cell therapy through the development of innovative immunotherapies for patients with cancer and other incurable diseases. The company was founded by David M. Hilbert and Luba Zaritskaya in December 2014 and is headquartered in Gaithersburg, MD.
    Address:25 West Watkins Mill Road,Suite A
    Website:http://www.arcellx.com

    Market Movers